Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 912029 | ISIN: US31428X1063 | Ticker-Symbol: FDX
Tradegate
17.01.25
21:07 Uhr
267,85 Euro
+0,15
+0,06 %
1-Jahres-Chart
FEDEX CORPORATION Chart 1 Jahr
5-Tage-Chart
FEDEX CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
267,45268,5517.01.
267,40268,0017.01.
ACCESS Newswire
914 Leser
Artikel bewerten:
(2)

FedEx Corporation: The Best of the Best: The Right Amount Construction

Finanznachrichten News

'The Best of the Best' Series: Celebrating the Recipients of the Hiring Our Heroes Small Business Award for Veterans & Military Spouses

NORTHAMPTON, MA / ACCESSWIRE / July 29, 2024 / In April, Hiring Our Heroes announced 5 grant recipients for the Small Business Award for Veterans & Military Spouses, an initiative that provides a one-time $10,000 grant for selected military-connected entrepreneurs, thanks to the generosity of the FedEx Founder's Fund. Selected grant recipients displayed both business acumen as well as two key characteristics - a dedication to overcoming economic hardships and a commitment to giving back to their communities.

In our 5-part blog series, we'll be meeting these grant recipients and learning more about the inspirational businesses that they have built and the passion that fuels them daily.

The first grant recipient is The Right Amount, LLC, doing business as TRA Construction in Baltimore, MD.

Gregory DiFranco started The Right Amount Construction (TRA), originally as an arm of an affordable housing development company working to tackle vacant housing. Brett Caropreso joined the company early in its expansion, bringing an immediate hands-on leadership derived from his experience as an Army Sergeant. Since then, they continue to systematically assemble a skilled and cohesive team that has allowed TRA to organically evolve into a general contractor that specializes in historic and complex building renovations in locations across the city and metropolitan area, no matter the neighborhood's socioeconomic status.

Gregory DiFranco started The Right Amount Construction (TRA), originally as an arm of an affordable housing development company working to tackle vacant housing. Brett Caropreso joined the company early in its expansion, bringing an immediate hands-on leadership derived from his experience as an Army Sergeant. Since then, they continue to systematically assemble a skilled and cohesive team that has allowed TRA to organically evolve into a general contractor that specializes in historic and complex building renovations in locations across the city and metropolitan area, no matter the neighborhood's socioeconomic status.

TRA has doubled its revenue annually since its inception and continues to grow as an equal opportunity and technically driven company. As military veterans, both DiFranco and Caropreso attribute the success of the company to their working relationships with each other and other members of the team, as well as their dedication to the work and professionalism. They know the best way to be successful is to assemble a team that can work autonomously get the job done right the first time. TRA Construction recruits team members using a thorough vetting process to ensure they are committed to their work and can contribute more knowledge to the company. One of their missions as a company is to hire a workforce that is from the communities they serve to convey the message that employees should be able to thrive with one source of income and ultimately afford to own similar houses to the ones they are working on.

TRA Construction aims to keep their commitment to their clients, however, they are focused heavily on keeping their team happy. DiFranco and Caropreso view success through a different lens - a lens that portrays success as employees living fulfilled lives. This is realized through honest feedback, regular raises, employee benefits, and a 4-day work week.

DiFranco and Caropreso brainstormed many ways they could put the grant money to use but it really came down to one priority - their people. "[We want to] take the money and put it back into the company to give [our] guys the tools they need to be as successful as possible," Caropreso said. The money will be used on technology and tools that the team uses daily, so that everyone feels stronger, healthier, and happier.

DiFranco and Caropreso have an overwhelming feeling of gratitude after being selected as a recipient of the Small Business Award for Veterans and Military Spouses. There are many businesses that do not have the resources to keep going. TRA Construction feels that with their military-based thinking and ability to push through obstacles, this grant will support their business and even further provide opportunities for more people that will continue to grow the local economy, all while giving people meaningful jobs and purpose.

Click here to learn about FedEx Cares, our global community engagement program.

View additional multimedia and more ESG storytelling from FedEx Corporation on 3blmedia.com.

Contact Info:
Spokesperson: FedEx Corporation
Website: https://www.3blmedia.com/profiles/fedex-corporation
Email: info@3blmedia.com

SOURCE: FedEx Corporation



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.